Vision

Seerave’s vision is to help prevent and defeat cancer and other immune-related diseases by enabling personalised modulation of the nutrition-microbiome-immune system axis.

Mission

Seerave's mission is to accelerate the generation of scientific evidence and its translation into innovative tools and treatments to enhance cancer care.

Science, translational and venture philanthropy

What we do

Science, translational and venture philanthropy

Seerave uses a combination of traditional grant donations towards academic researchers as well as equity investments into early-stage start-ups. Our project portfolio is built around international alliances of world-leading institutions, visionary scientists and entrepreneurs.

Our Projects and Investments

Watch our founder, David Rees, sharing his perspective

Proactive Family Foundation

About us

Proactive Family Foundation

Inspired by personal experiences, Seerave was founded in 2015 driven by the conviction that the nutrition-microbiome-immune system axis is a significant contributor to the future of personalised cancer treatment.

About Seerave
  • Nutrition
  • Microbiome
  • Metabolites
  • Immune System
  • Personalised Cancer Treatments
  • Nutrition
  • Microbiome
  • Metabolites
  • Immune System
  • Personalised Cancer Treatments
  • Nutrition
  • Microbiome
  • Metabolites
  • Immune System
  • Personalised Cancer Treatments
  • Nutrition
  • Microbiome
  • Metabolites
  • Immune System
  • Personalised Cancer Treatments
  • Involved
  • Pragmatic
  • Proactive
  • Collaborative
  • Open Science
  • Holistic
  • Involved
  • Pragmatic
  • Proactive
  • Collaborative
  • Open Science
  • Holistic
  • Involved
  • Pragmatic
  • Proactive
  • Collaborative
  • Open Science
  • Holistic
  • Involved
  • Pragmatic
  • Proactive
  • Collaborative
  • Open Science
  • Holistic
  • Biomarker Discovery
  • Novel Tools
  • Preclinical Studies
  • Clinical Feasibility
  • Clinical Implementation
  • Biomarker Discovery
  • Novel Tools
  • Preclinical Studies
  • Clinical Feasibility
  • Clinical Implementation
  • Biomarker Discovery
  • Novel Tools
  • Preclinical Studies
  • Clinical Feasibility
  • Clinical Implementation
  • Biomarker Discovery
  • Novel Tools
  • Preclinical Studies
  • Clinical Feasibility
  • Clinical Implementation
Learn about our Approach

FAQ

I would like to ask you about...

We are an active and innovative family foundation. We are inspired by personal experiences and driven by the conviction that through collaboration we will be able to accelerate science and catalyse innovation to enable personalised cancer treatment.
Seerave uses a combination of traditional grant donations towards academic researchers as well as equity investments into early-stage start-ups. Our project portfolio is built around international alliances of world-leading institutions, visionary scientists and entrepreneurs.
Yes. We are a registered NPO under Non-Profit Organisations (Jersey) Law 2008, with registration number NPO-7095.
The funding comes from a family endowment. David Rees co-founded the downstream oil company Greenergy, which was sold in May 2017 and the resulting proceeds were bequeathed to Seerave to fund its philanthropic activities.